Conflicts of Interest
Management of Anticoagulation Therapy
Daniel M. Witt, PharmD, University of Utah
Nathan P. Clark, PharmD, Kaiser Permanente Colorado
Jane Skov, PhD, MSc, University of Southern Denmark
Mark Crowther, MD, MSc, McMaster University
Drs. Clark, Skov, and Crowther declare no competing financial interests. Dr. Witt has received funding from Roche Diagnostics.
Venous Thromboembolism (VTE) in the Context of Pregnancy
Shannon M. Bates, MDCM, MSc, McMaster University
Anita Rajasekhar, MD, MS, University of Florida
Claire McLintock, MD, National Women’s Health, Auckland City Hospital
Conflict of interest information pending.
Diagnosis and Management of Heparin-Induced Thrombocytopenia (HIT)
Allyson M. Pishko, MD, University of Pennsylvania
Lori-Ann Linkins, MD, MSc, McMaster University
Theodore E. Warkentin, MD, McMaster University
Adam Cuker, MD, MS, University of Pennsylvania
Drs. Pishko, Linkin, Warkentin, and Cuker declare no competing financial interests.
Management of Immune Thrombocytopenia (ITP)
Cindy Neunert, MD, Columbia University Medical Center
Sara K. Vesely, PhD, University of Oklahoma Health Sciences Center
Siraj Mithoowani, MD, McMaster University
Taylor Kim, MD, Baylor College of Medicine
Conflict of interest information pending.
Cardiopulmonary and Kidney Disease in Sickle Cell Disease: Screening and Management
Robert I. Liem, MD, Ann & Robert H. Lurie Children’s Hospital of Chicago
Sophie Lanzkron, MD, Johns Hopkins School of Medicine
Madeleine Verhovsek, MD, FRCPC, McMaster University
Ifeyinwa (Ify) Osunkwo, MD, MPH, The Levine Cancer Institute – Atrium Health
Conflict of interest information pending.
2013 Clinical Practice Guide on Thrombocytopenia in Pregnancy
Anita Rajasekhar, MD, MS
Terry Gernsheimer, MD
Roberto Stasi, MD, PhD
Andra H. James, MD, MPH
No declared conflicts of interest.
Management of Acute Complications of Sickle Cell Disease
Timothy McCavit, MD, MSCS, University of Texas Southwestern Medical Center
Payal Desai, MD, The Ohio State University, the James Cancer Center
Dr. Desai is a consultant for Pfizer. Dr. McCavit is a consultant for Pfizer and was previously a consultant for GlycoMimetics.
Health Maintenance and Management of Chronic Complications of Sickle Cell Disease
Suzie A. Noronha, MD, University of Rochester Medical Center
Sophie Lanzkron, MD, Johns Hopkins University School of Medicine
Dr. Lanzkron receives research funding from Selexys Pharmaceuticals and from NKT Therapeutics. Dr. Noronha receives research funding from Mast Therapeutics.
Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease
Susan E. Creary, MD, MSc, The Ohio State University School of Medicine
John J. Strouse, MD, PhD, Johns Hopkins University School of Medicine
Dr. Creary declares no competing financial interests. Dr. Strouse is co-investigator on an NHLBI grant, 1R34HL108756-01, to study hydroxyurea for the primary prevention of central nervous system disease in young children with sickle cell anemia.
Initial Diagnostic Workup of Acute Leukemia
Melissa H. Cessna, MD, Intermountain Healthcare and Utah Pathology Services, Inc.
Sa A. Wang, MD, The University of Texas MD Anderson Cancer Center
Drs. Cessna and Wang declare no competing financial interests.
Monoclonal Gammopathy of Undetermined Significance (MGUS): Diagnosis, Predictors of Progression, and Monitoring
Brea C. Lipe, MD University of Rochester Medical Center
Robert A. Kyle, MD Mayo Clinic, Rochester, MN
Drs. Lipe and Kyle declare no competing financial interests.
Red Blood Cell Transfusion
Robert Weinstein, MD, University of Massachusetts Medical School
Dr. Weinstein declares no competing financial interests.
2012 Clinical Practice Guideline on the Evaluation and Management of von Willebrand Disease (VWD)
No authors listed2011 Clinical Practice Guideline on the Evaluation and Management of Immune Thrombocytopenia (ITP) -DISCONTINUED
No authors listedClinical Practice Guide on Antithrombotic Drug Dosing and Management of Antithrombotic Drug-Associated Bleeding Complications in Adults- DISCONTINUED
Mary Cushman, University of VermontWendy Lim, McMaster University
Neil A. Zakai, University of Vermont
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission